ProShares Ultra Nasdaq Biotechnology BIB
118.78 USD +1.53 (+1.30%)
At closeNov 4, 2026, 6:07 AM EST
190.04 +71.26 +60.00%
Pre-market · Nov 4, 6:07 AM ET
117.73 Day range 120.43
67.50 52-week range 126.40
- YTD
- +48.88%
- 1 year
- +70.54%
- Market cap
- 102.15M
- EPS (ttm)
- 3.53
- P/E ratio
- 33.64
- YTD return
- +48.88%
- 1-year return
- +70.54%
- Volume
- 5.28K
- Avg volume
- 9.88K
- Open
- 117.73
- Previous close
- 117.25
- Day's range
- 117.73 – 120.43
- 52-week range
- 67.50 – 126.40
2Y +56.89 (+91.92%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 59.52
- 200-day average
- 59.79
About ProShares Ultra Nasdaq Biotechnology
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on BIB — it syncs with the Stock Master app.